Literature DB >> 1730919

Dendritic cells are potent antigen-presenting cells for microbial superantigens.

N Bhardwaj1, S M Friedman, B C Cole, A J Nisanian.   

Abstract

Dendritic cells are a small subset of human blood mononuclear cells that are potent stimulators of several T cell functions. Here we show they are 10-50-fold more potent than monocytes or B cells in inducing T cell responses to a panel of superantigens. Furthermore, dendritic cells can present femtomolar concentrations of superantigen to T cells even at numbers where other antigen-presenting cells (APCs) are inactive. Although dendritic cells express very high levels of the major histocompatibility complex products that are required to present superantigens, it is only necessary to pulse these APCs for 1 hour with picomolar levels of one superantigen, staphylococcal enterotoxin B, to maximally activate T cells. Our results suggest that very small amounts of superantigen will be immunogenic in vivo if presented on dendritic cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1730919      PMCID: PMC2119099          DOI: 10.1084/jem.175.1.267

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  36 in total

1.  Class II MHC molecules are specific receptors for staphylococcus enterotoxin A.

Authors:  J A Mollick; R G Cook; R R Rich
Journal:  Science       Date:  1989-05-19       Impact factor: 47.728

2.  High-affinity binding of staphylococcal enterotoxins A and B to HLA-DR.

Authors:  J D Fraser
Journal:  Nature       Date:  1989-05-18       Impact factor: 49.962

3.  Interaction of Staphylococcus aureus toxin "superantigens" with human T cells.

Authors:  Y W Choi; B Kotzin; L Herron; J Callahan; P Marrack; J Kappler
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

4.  Toxic shock syndrome toxin 1 binds to major histocompatibility complex class II molecules.

Authors:  P Scholl; A Diez; W Mourad; J Parsonnet; R S Geha; T Chatila
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

5.  Relative efficacy of human monocytes and dendritic cells as accessory cells for T cell replication.

Authors:  W C Van Voorhis; J Valinsky; E Hoffman; J Luban; L S Hair; R M Steinman
Journal:  J Exp Med       Date:  1983-07-01       Impact factor: 14.307

6.  Cultured human Langerhans cells resemble lymphoid dendritic cells in phenotype and function.

Authors:  N Romani; A Lenz; H Glassel; H Stössel; U Stanzl; O Majdic; P Fritsch; G Schuler
Journal:  J Invest Dermatol       Date:  1989-11       Impact factor: 8.551

7.  V beta-specific stimulation of human T cells by staphylococcal toxins.

Authors:  J Kappler; B Kotzin; L Herron; E W Gelfand; R D Bigler; A Boylston; S Carrel; D N Posnett; Y Choi; P Marrack
Journal:  Science       Date:  1989-05-19       Impact factor: 47.728

8.  The V beta-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice.

Authors:  J White; A Herman; A M Pullen; R Kubo; J W Kappler; P Marrack
Journal:  Cell       Date:  1989-01-13       Impact factor: 41.582

9.  The staphylococcal toxic shock syndrome toxin 1 triggers B cell proliferation and differentiation via major histocompatibility complex-unrestricted cognate T/B cell interaction.

Authors:  W Mourad; P Scholl; A Diaz; R Geha; T Chatila
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

10.  Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and gamma interferon.

Authors:  C Jupin; S Anderson; C Damais; J E Alouf; M Parant
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

View more
  32 in total

Review 1.  The role of the skin microbiome in atopic dermatitis.

Authors:  Michael R Williams; Richard L Gallo
Journal:  Curr Allergy Asthma Rep       Date:  2015-11       Impact factor: 4.806

Review 2.  Exploiting dendritic cells for active immunotherapy of cancer and chronic infections.

Authors:  David W O'Neill; Nina Bhardwaj
Journal:  Mol Biotechnol       Date:  2007-06       Impact factor: 2.695

3.  Epidermal Langerhans' cell induction of immunity against an ultraviolet-induced skin tumour.

Authors:  L L Cavanagh; R Sluyter; K G Henderson; R S Barnetson; G M Halliday
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

4.  Porcine dendritic cells generated in vitro: morphological, phenotypic and functional properties.

Authors:  C P Carrasco; R C Rigden; R Schaffner; H Gerber; V Neuhaus; S Inumaru; H Takamatsu; G Bertoni; K C McCullough; A Summerfield
Journal:  Immunology       Date:  2001-10       Impact factor: 7.397

Review 5.  Revenge of the microbes. Superantigens of the T and B cell lineage.

Authors:  L Goodglick; J Braun
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

6.  Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells.

Authors:  N Bhardwaj; A Bender; N Gonzalez; L K Bui; M C Garrett; R M Steinman
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

7.  Myeloid Dendritic Cells Induce HIV Latency in Proliferating CD4+ T Cells.

Authors:  Nitasha A Kumar; Renee M van der Sluis; Talia Mota; Rachel Pascoe; Vanessa A Evans; Sharon R Lewin; Paul U Cameron
Journal:  J Immunol       Date:  2018-07-20       Impact factor: 5.422

8.  Lipopolysaccharide-induced maturation of bone marrow-derived dendritic cells is regulated by notch signaling through the up-regulation of CXCR4.

Authors:  Yao-Chun Wang; Xing-Bin Hu; Fei He; Fan Feng; Lin Wang; Wei Li; Ping Zhang; Duan Li; Zhan-Sheng Jia; Ying-Min Liang; Hua Han
Journal:  J Biol Chem       Date:  2009-04-07       Impact factor: 5.157

Review 9.  Molecular biology and pathogenicity of mycoplasmas.

Authors:  S Razin; D Yogev; Y Naot
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

10.  Biased epitope selection by recombinant vaccinia-virus (rVV)-infected mature or immature dendritic cells.

Authors:  D Nagorsen; M Panelli; M E Dudley; S E Finkelstein; S A Rosenberg; F M Marincola
Journal:  Gene Ther       Date:  2003-09       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.